Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Company Profile and bullboard matches:

T.TRI
Sort by: Date|Relevance

Silver price predictions: Is the 2024 gold and silver rally just starting?

By Rob Driscoll Like birds of a feather, gold and silver have historically flocked together, and the two precious metal mates have certainly found their wings in 2024. Gold hit an all-time high in April, and silver parroted the move by breaching the $29 mark l...
Research | April 19, 2024 |

A world energy crisis driving a renewed interest in uranium

Welcome to The Market Herald Canada’s Capital Compass. Many companies are considering a new path to clean energy in the fight against climate change. Our next company is publicly traded on the venture exchange and is utilizing uranium in this pursuit...
Brieanna McCutcheon | October 24, 2023 |

Why Fortune Favours Chris Taylor’s Kodiak Copper

It’s a stark new reality. And investors need to listen up or lose out. Truth be told, it is no longer only the size and grade of each new mineral discovery that determines whether it can become a mine. Now, all exploration/development projects also need to ...
Marc Davis | January 24, 2022 |

Canagold: Sweet Surprise as a High-Grade Low-Cost Gold Deposit Delivers

It’s a big shot in the arm that promises to redouble the considerable scarcity value of the New Polaris gold deposit. A one-million-ounce gold deposit that is owned by Canagold Resources ( TSX: CCM ) (OTCBB: CRCUF) ( Frankfurt: CANA), New Polaris may be ...
Marc Davis | September 22, 2021 |

XPhyto: Buyouts, Biosensors and a Booming Business

Test, test, test! It’s the World Health Organization’s battle cry in the global war against COVID-19 and other coronaviruses – including future outbreaks. And it is not getting any less resonant as new variants continue to cause ha...
Marc Davis | August 3, 2021 |

Falcon Gold Buys Newfoundland Gold Project as CEO Karim Rayani Backs Company in the most Meaningful

On July 13, 2021 Falcon Gold (FG.V) announced that it has acquired a significant land position within the Hope Brook Area, Newfoundland . Falcon Gold has de-risked itself significantly by acquiring and developing multiple projects in multiple jurisdictions. That is a...
Lukas Kane | July 14, 2021 |

NervGen Pharma: A “Blockbuster Drug” in the Making?

It has the potential to be one of the most disruptive pharmaceutical drug therapies of the modern era, especially for treating Alzheimer’s disease. And that gives it considerable “blockbuster drug” potential – a tantalising opportunity tha...
Marc Davis | June 25, 2021 |

XPhyto: Proof of Concept for Mescalin Synthesis

It’s become a much talked-about story on both sides of the Atlantic. XPhyto Therapeutics Corp. ( CSE: XPHY ) (FSE: 4XT) (OTCQB: XPHYF) has earned considerable media coverage in recent months due to its expansion into the development of psychedelic d...
Marc Davis | June 9, 2021 |

XPhyto Therapeutics: Are they Selling the Solution to Germany’s Rapid Testing Crisis?

The Germans call it COVID-19 “rapid testing mania”. But like most manias, it has opened up a Pandora’s box of problems. As the speed of the vaccine rollout program falters in Europe, on-the-spot antigen testing continues to be the ...
Marc Davis | June 2, 2021 |

A Life Sciences Project Accelerator Kicks into High Gear

XPhyto Therapeutics Corp. ( CSE: XPHY ) (FSE: 4XT) (OTC: XPHYF) has been a hot story lately, especially in Germany, due to its recent commercialization of a super-fast PCR test kit for definitively diagnosing COVID-19 infections in point-of-care settings. The company rec...
Marc Davis | May 10, 2021 |
1 2 3 4 5 6 7 8 9